About TECHLAB
TECHLAB is a company based in United States founded in 1989 was acquired by SSI Diagnostica in August 2022. TECHLAB offers products and services including C. DIFF QUIK CHEK COMPLETE, LEUKO EZ VUE, and IMMUVIEW. TECHLAB operates in a competitive market with competitors including Prometheus Laboratories, InDex Pharmaceuticals, Viome Life Sciences, NinePoint Medical and Given Imaging, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Techlab, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$599.26 K (USD), Grant
Jun 04, 2012
-
Investors
HHS
& 2 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TECHLAB
TECHLAB offers a comprehensive portfolio of products and services, including C. DIFF QUIK CHEK COMPLETE, LEUKO EZ VUE, and IMMUVIEW.
Rapid test for detecting C. difficile toxins and antigens
Test for detecting fecal lactoferrin as intestinal inflammation marker
Urinary antigen test for S. pneumoniae and L. pneumophila
People of TECHLAB
Unlock access to complete
Funding Insights of TECHLAB
Investors in TECHLAB
TECHLAB has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, SSI Diagnostica and Pharos Capital Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are made to improve patient outcomes.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Diagnostic and quality control testing kits are manufactured.
|
Locked | Locked | Locked |
Investor details for TECHLAB
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TECHLAB
Investment portfolio details for TECHLAB
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TECHLAB
Detailed financials for TECHLAB
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Techlab Comparisons
Peer comparison for TECHLAB
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TECHLAB
TECHLAB operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prometheus Laboratories, InDex Pharmaceuticals, Viome Life Sciences, NinePoint Medical and Given Imaging, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostics and therapeutics for gastrointestinal and personalized medicine are developed.
|
|
| Locked | Locked | Locked |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| Locked | Locked | Locked |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| Locked | Locked | Locked |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| Locked | Locked | Locked |
Capsule endoscopy systems for GI imaging
|
|
| Locked | Locked | Locked |
Ingestible biosensor for GI disease
|
Detailed competitors of TECHLAB
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Techlab
Complete news archive for TECHLAB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TECHLAB
TECHLAB was founded in 1989 and raised its 1st funding round 15 years after it was founded.
TECHLAB is headquartered in United States.
TechLab was founded in 1989 in the United States and specializes in the development and manufacturing of diagnostic tests for gastrointestinal diseases. Tests are offered in formats including Rapid EIA, Microplate ELISA, Lateral Flow, and Tissue culture, targeting areas such as colitis, parasitology, intestinal inflammation, and Shiga toxins from enterohemorrhagic E. coli. The patented QUIK CHEK technology enables results in under 30 minutes. Global distribution is handled by Alere.
TECHLAB's top competitors include Viome Life Sciences, Prometheus Laboratories and NinePoint Medical.
TECHLAB offers C. DIFF QUIK CHEK COMPLETE, LEUKO EZ VUE, and IMMUVIEW.
TECHLAB has 3 investors. Key investors include HHS, SSI Diagnostica, and Pharos Capital Group.